We had previously shown that albumin and its derivative, R-III (a retinol-binding protein-albumin domain III fusion protein), inhibited HSC activation by sequestering retinoic acid (RA) and that R-III administration reduced carbon tetrachloride (CCl<sub>4</sub>)-induced liver fibrosis. The gene discussed is ALB; the disease is Hepatic fibrosis.